Loading clinical trials...
Loading clinical trials...
Critically ill Patients are at high risk to develop deep venous thrombosis. However, despite receiving of a standard dose of Low-molecular-weight Heparin（LMWH）, many patients still develop life-threat...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Southeast University, China
NCT06840756 · Red Blood Cell Transfusions, Sex Differences, and more
NCT07448805 · Diabetes Mellitus, Blood Sugar, and more
NCT07222007 · Critically Ill, Intubation Complication, and more
NCT07093450 · Infection, Antimicrobial Stewardship, and more
NCT07143695 · Critically Ill
Changde Wu
Nanjing, Jiangsu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions